Isarna Therapeutics



Description: 

Isarna Therapeutics develops TGF-β inhibitors to effectively treat ophthalmic and fibrotic diseases and fight cancer. The company uses novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.

Location(s): 
Munich
Germany